In 2018, Stanford ChEM-H will provide a special opportunity for up to two physician-scientists with a strong background in chemistry or molecular engineering to develop an independent research program, as they complete their fellowship. The program is designed for incoming fellows who hold M.D./Ph.D. degrees and are committed to pursuing research-intensive training in any of the clinical departments at Stanford University. Research areas of greatest interest are ones that bridge the physical sciences or engineering with medicine.
April 16, 2018
Successful applicants will receive up to two years of support (maximum $125K) for a research technician and/or study-related expenses (e.g. supplies, instrument charges, etc.). It is expected that such support will enable the candidate to undertake exploratory research and to obtain preliminary data that allows him/her to successfully compete for a longer-term extramural career development award (e.g. K08 or K99). A host laboratory and mentor will also be identified for this two-year period, to help the candidate achieve his/her research and career goals. Funding will be available beginning July 1, 2018 and should be expended by June 30, 2020.
Eligible candidates are M.D./Ph.D. degree holders who have matched to any fellowship program at Stanford and are interested in pursuing research in parallel with their postdoctoral clinical training. Candidates with Ph.D. degrees in the physical sciences or engineering or who have indicated an interest in the Translational Investigator Program (TIP) are encouraged to apply.
Applications will be reviewed by a faculty panel consisting of Stanford ChEM-H affiliated faculty. Applications will be selected by June 1, 2018 and funded effective July 1, 2018.
Interested candidates are encouraged to contact Dr. Katherine Alfieri, ChEM-H Program Manager: firstname.lastname@example.org.
2017 ChEM-H Physician-Scientist Research Fellow
Marie Hollenhorst, MD, PhD
Marie’s interest in a career as a physician-scientist began during her time as an undergraduate at Stanford where she studied biology. She subsequently enrolled in the Harvard-MIT MD/PhD program, where she pursued an MD through the Harvard-MIT Health Sciences and Technology Program and a PhD in Chemical Biology. She carried out her thesis work in the research group of Christopher T. Walsh, focusing on the biosynthesis and biological activity of a family of natural product peptide antibiotics. She completed internal medicine residency at Brigham and Women’s Hospital and a fellowship in transfusion medicine at Harvard. She is thrilled to be back at Stanford for Hematology fellowship and excited to become a part of the ChEM-H community. Going forward, she hopes to combine her clinical interests in non-malignant hematologic disease with her background in chemical biology in order to bring a chemical approach to the study of benign blood diseases.